Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
filingDate |
2014-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cab01eef9c215390d017cc14d921347d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eed7b645122aeb0eee3b185fd04bfc55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53a5b5e6ceed8d4da8eb5a154037e706 |
publicationDate |
2015-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-201542547-A |
titleOfInvention |
Novel quinoline substituted compounds |
abstract |
An object of the present invention is to provide a novel compound having an EGFR inhibitory action and having a cell proliferation inhibiting effect. Further, based on the EGFR inhibitory action, a medicine useful for the prevention and/or treatment of cancer is provided.nThe solution is a compound of the following formula (I) or a salt thereof:n□ |
priorityDate |
2013-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |